PMID: 16507221Mar 2, 2006Paper

Interleukins 18 and 21: biology, mechanisms of action, toxicity, and clinical activity

Current Oncology Reports
Theodore Logan, Michael J Robertson

Abstract

Interleukins 18 and 21 have been described, and the effect of each upon immune response and experimental tumors in animals has been the subject of much recent work. Both interleukins have shown antitumor effects in animals, which in some models are striking for their duration, specificity, and ability to protect against rechallenge with the same tumor. These characteristics suggest immunologic involvement in the antitumor response, and several papers suggest involvement of both innate and adaptive immune mechanisms. Recent early phase I clinical trials in human cancer patients have demonstrated evidence of clinical response. This review discusses the biology, preclinical animal tumor model data, and early clinical trial findings.

References

Jan 1, 1970·Progress in Experimental Tumor Research·F M Burnet
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Feb 15, 1996·Nature·J F BazanR A Kastelein
Jun 1, 1997·Immunology Today·T BoonB Van den Eynde
May 23, 1998·The Journal of Experimental Medicine·L J Old, Y T Chen
Dec 14, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R CaoY Cao
Apr 4, 2000·Journal of Immunotherapy·T KikuchiT Ohno
Jul 7, 2000·The Journal of Infectious Diseases·R VankayalapatiP F Barnes
Oct 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·K OzakiW J Leonard
Aug 8, 2001·The Journal of Experimental Medicine·S L Swain
May 3, 2002·Blood·Anne-Tove BrenneHenrik Hjorth-Hansen
Jun 6, 2002·Journal of Immunotherapy·Sachiko AkamatsuMasashi Kurimoto
Oct 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jon M WiggintonRobert H Wiltrout
Jan 30, 2003·Journal of Leukocyte Biology·J Alastair GracieIain B McInnes
Jul 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hak-Ling MaKyriaki Dunussi-Joannopoulos
Jan 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emma Di CarloSilvano Ferrini
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jason BradyStephen L Nutt
Mar 9, 2004·Postȩpy higieny i medycyny doświadczalnej·Marek Fol, Teresa Gościcka
Mar 24, 2004·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Takuya OkamotoNobuyuki Terada
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adrianna MorozProtul A Shrikant
Nov 18, 2004·Immunological Reviews·Devangi S MehtaMichael J Grusby
Nov 18, 2004·Immunological Reviews·Mark J SmythYoshihiro Hayakawa
Nov 19, 2004·Current Opinion in Hematology·Pavan Reddy
Dec 14, 2004·Critical Reviews in Immunology·Stephen L NuttMark J Smyth
Jan 5, 2005·The Journal of Experimental Medicine·Rong ZengWarren J Leonard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Robert ZeiserRobert S Negrin
Annals of the Rheumatic Diseases
Sheng-Ming DaiKusuki Nishioka
© 2021 Meta ULC. All rights reserved